FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114348515> ?p ?o ?g. }

• W3114348515 abstract "Just as basic science has shown unparalleled cooperation to increase basic and clinical understanding of SARS-Cov2, the vaccine industry has raced towards being first to develop vaccines against Covid-19. The success has been formidable. Never before has so many novel and efficient vaccines been produced with such speed1 and phase 2/3 trials showing clinical efficacy are now accumulating.2 Concerns are raised that safety might lag behind, but Covid-19 is a very deadly disease and the earlier vaccines are in place, the more lives can be saved. In this time race, there is a delicate balance between approval and taking the risk that very rare side effects reveal themselves. But as vaccines are being administered, lives will be spared and the SARS-Cov2 pandemic reaches its end. It is a safe bet that immunology in 2021 will focus on vaccines against Covid-19. Vaccines have a long history of public health successes starting with Jenner's smallpox vaccinations in 1796 leading to its eradication in the 1960s. Already one decade earlier, Salk developed a Polio vaccine, which has since then saved millions of children from debilitating disease. Today, general vaccination programmes cover many diseases such as diphtheria, measles, mumps and rubella. In addition, vaccines protect us against tropical diseases such as the yellow fever, and neurological sequelae from tick-borne encephalitis can be almost completely prevented following a completed vaccination programme. Not all diseases are easy to substitute with a vaccine, however, and some diseases, such as, for example HIV, malaria and tuberculosis (incidentally diseases that are often prevalent in low income countries), remain more elusive. Research on basic immunology of these diseases is encouraged in this journal,3-5 as are studies on immune responses to vaccination in general.6, 7 In 2021, we will put a special emphasis on studies that enhance the knowledge on how vaccines influence the immune system and how they protect against diseases. Submission of original studies in this area is encouraged. Resistance to vaccination in society is unfortunately increasing, which in the case of Covid-19 threatens the development of herd immunity and slows down societal recovery from the pandemic. This scepticism is psychologically understandable to some degree, given the disastrous cases of narcolepsy that occurred in some children after the recent swine flu vaccine Pandemrix.8 Vaccine resistance also stems from incorrect perceptions, however, such as the one that childhood vaccination, in particular against measles, causes autism, something that has been disproven many times, including in a recent Danish study on over 650 000 vaccinated children.9 In additions, misconceptions exist that the immune system might be weakened by vaccination compared to seeing the “real thing”, but potential deadly and disabling effects of the disease in question are often neglected. Devastating side effects of vaccinations must of course be avoided at all costs. It remains very difficult, however, to predict complications so rare that they are not revealed until tens of thousands, or even more, individuals have been vaccinated. And, as mentioned earlier, there is always another side of the coin: the prospect of saving lives that without the vaccine would be lost to the disease. It is clear to anyone who studies the history of infectious diseases that vaccination remains one of our most important human health inventions. In the era of modern medicine, hygiene and life standards, it is easy to forget that vaccination has saved billions of lives and prevented major suffering for many more. As immunologists, we must defend vaccination as a public health measure of increasing importance. We must do so by presenting facts, counteracting misinformation and engaging in the debate. Above all, we have a duty to perform high quality science to investigate mechanisms underlying immune responses to infectious diseases, with the aim not only to understand the disease better, but also to identify new avenues to improve vaccine efficacy and minimizing side effects. The Scandinavian Journal of Immunology will do its best to support the research community in this quest." @default.
• W3114348515 created "2021-01-05" @default.
• W3114348515 creator A5040973657 @default.
• W3114348515 date "2020-12-28" @default.
• W3114348515 modified "2023-09-25" @default.
• W3114348515 title "Talk of the town in 2021: Covid‐19 vaccines likely take centre stage" @default.
• W3114348515 cites W2073937907 @default.
• W3114348515 cites W2806736950 @default.
• W3114348515 cites W2902588119 @default.
• W3114348515 cites W2944479733 @default.
• W3114348515 cites W2955864174 @default.
• W3114348515 cites W2971524645 @default.
• W3114348515 cites W3044212219 @default.
• W3114348515 cites W3087924281 @default.
• W3114348515 cites W4376522559 @default.
• W3114348515 doi "https://doi.org/10.1111/sji.13014" @default.
• W3114348515 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7883282" @default.
• W3114348515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33372339" @default.
• W3114348515 hasPublicationYear "2020" @default.
• W3114348515 type Work @default.
• W3114348515 sameAs 3114348515 @default.
• W3114348515 citedByCount "0" @default.
• W3114348515 crossrefType "journal-article" @default.
• W3114348515 hasAuthorship W3114348515A5040973657 @default.
• W3114348515 hasBestOaLocation W31143485151 @default.
• W3114348515 hasConcept C142724271 @default.
• W3114348515 hasConcept C159047783 @default.
• W3114348515 hasConcept C203014093 @default.
• W3114348515 hasConcept C22070199 @default.
• W3114348515 hasConcept C2776438120 @default.
• W3114348515 hasConcept C2778417375 @default.
• W3114348515 hasConcept C2778814567 @default.
• W3114348515 hasConcept C2779134260 @default.
• W3114348515 hasConcept C2780572238 @default.
• W3114348515 hasConcept C3008058167 @default.
• W3114348515 hasConcept C4870876 @default.
• W3114348515 hasConcept C524204448 @default.
• W3114348515 hasConcept C71924100 @default.
• W3114348515 hasConcept C89623803 @default.
• W3114348515 hasConceptScore W3114348515C142724271 @default.
• W3114348515 hasConceptScore W3114348515C159047783 @default.
• W3114348515 hasConceptScore W3114348515C203014093 @default.
• W3114348515 hasConceptScore W3114348515C22070199 @default.
• W3114348515 hasConceptScore W3114348515C2776438120 @default.
• W3114348515 hasConceptScore W3114348515C2778417375 @default.
• W3114348515 hasConceptScore W3114348515C2778814567 @default.
• W3114348515 hasConceptScore W3114348515C2779134260 @default.
• W3114348515 hasConceptScore W3114348515C2780572238 @default.
• W3114348515 hasConceptScore W3114348515C3008058167 @default.
• W3114348515 hasConceptScore W3114348515C4870876 @default.
• W3114348515 hasConceptScore W3114348515C524204448 @default.
• W3114348515 hasConceptScore W3114348515C71924100 @default.
• W3114348515 hasConceptScore W3114348515C89623803 @default.
• W3114348515 hasIssue "1" @default.
• W3114348515 hasLocation W31143485151 @default.
• W3114348515 hasLocation W31143485152 @default.
• W3114348515 hasOpenAccess W3114348515 @default.
• W3114348515 hasPrimaryLocation W31143485151 @default.
• W3114348515 hasRelatedWork W1494397300 @default.
• W3114348515 hasRelatedWork W2042250827 @default.
• W3114348515 hasRelatedWork W2058305415 @default.
• W3114348515 hasRelatedWork W2092315933 @default.
• W3114348515 hasRelatedWork W2132943516 @default.
• W3114348515 hasRelatedWork W2330251861 @default.
• W3114348515 hasRelatedWork W2411804863 @default.
• W3114348515 hasRelatedWork W2463418567 @default.
• W3114348515 hasRelatedWork W2842117546 @default.
• W3114348515 hasRelatedWork W2304036889 @default.
• W3114348515 hasVolume "93" @default.
• W3114348515 isParatext "false" @default.
• W3114348515 isRetracted "false" @default.
• W3114348515 magId "3114348515" @default.
• W3114348515 workType "article" @default.